BIFOCUS LABS:
Immune-stimulative effect of Salicinium on immune-cells from cancer patients
Dr. Lothar Prix, Biofocus GmbH, Recklinghausen, Germany. www.biofocus.de
Methods: Immune cells were obtained from blood samples of nine cancer patients. The capability of these immune cells to kill tumor cells in vitro was determined by using a cellular NK-test (Neri et al, Clin Diagn Lab Immunol. 2001 November; 8(6): 1131–1135). The basal killing activity was compared to the killing activity after treatment of the immune cells with Salicinium and the mistletoe extract Lektinol.
Results:
Patient # basal killing activity additional killing actitivty (%) additional killing activity (%)
(% of lysis) after treatment with Salicinium after treatment with Lektinol
1 7 28 11
2 17 17 15
3 14 31 8
4 34 6 28
5 37 3 10
6 13 41 36
7 9 21 18
8 31 32 46
9 9 39 15
*** Patients 4 and 5 were control samples with no tumor***
BioFocus Labs Cellular NK test measures the percentage of lysis or the killing capacity of the immune cells, the results are also provided below.